Swiss National Bank’s CureVac CVAC Stock Holding History

Swiss National Bank’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-193,579	Closed	-$1.03M	–	2326
2025 Q3	$1.03M	Hold	193,579	–	–	﹤0.01%	2154
2025 Q2	$1.04M	Sell	193,579 -4,968	-3%	-$19.7K	﹤0.01%	2124
2025 Q1	$553K	Hold	198,547	–	–	﹤0.01%	2324
2024 Q4	$621K	Hold	198,547	–	–	﹤0.01%	2360
2024 Q3	$613K	Hold	198,547	–	–	﹤0.01%	2386
2024 Q2	$658K	Hold	198,547	–	–	﹤0.01%	2350
2024 Q1	$611K	Hold	198,547	–	–	﹤0.01%	2411
2023 Q4	$846K	Sell	198,547 -22,859	-10%	-$124K	﹤0.01%	2331
2023 Q3	$1.46M	Buy	221,406 +3,925	+2%	+$34.7K	﹤0.01%	2023
2023 Q2	$2.3M	Buy	217,481 +94,270	+77%	+$843K	﹤0.01%	1790
2023 Q1	$860K	Sell	123,211 -12,586	-9%	-$110K	﹤0.01%	2336
2022 Q4	$825K	Buy	135,797 +3,746	+3%	+$27.7K	﹤0.01%	2435
2022 Q3	$1.08M	Hold	132,051	–	–	﹤0.01%	2296
2022 Q2	$1.79M	Buy	+132,051	New	+$2.18M	﹤0.01%	2001

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Swiss National Bank's CVAC Position: Q4 2025 in Review

Swiss National Bank sold out of CureVac (CVAC) in Q4 2025, closing a stake of 193,579 shares — an estimated $1.03M sold.

Swiss National Bank first reported a position in CVAC in Q2 2022 and held it in 14 quarters. The position peaked at $2.3M in Q2 2023. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Swiss National Bank reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Swiss National Bank sold 193,579 CureVac shares in Q4 2025, an estimated $1.03M.
Swiss National Bank first reported a position in CureVac in Q2 2022 and held it in 14 quarters.
Swiss National Bank's CureVac position peaked at $2.3M in Q2 2023.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.